Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing

Reinhard Zeidler, Gilbert Reisbach, Barbara Wollenberg, Stephan Lang, Sarita Chaubal, Bärbel Schmitt, Horst Lindhofer

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

188 Zitate (Scopus)

Abstract

Bispecific Abs (bsAb) are promising immunological tools for the elimination of tumor cells in minimal residual disease situations. In principle, they target an Ag on tumor cells and recruit one class of effector cell. Because immune reactions in vivo are more complex and are mediated by different classes of effector cell, we argue that conventional bsAb might not yield optimal immune responses at the tumor site. We therefore constructed a bsAb that combines the two potent effector subclasses mouse IgG2a and rat IgG2b. This bispecific molecule not only recruits T cells via its one binding arm, but simultaneously activates FcγR+ accessory cells via its Fc region. We demonstrate here that the activation of both T lymphocytes and accessory cells leads to production of immunomodulating cytokines like IL-1β, IL-2, IL-6, IL-12, and DC-CK1. Thus this new class of bsAb elicits excellent antitumor activity in vitro even without the addition of exogenous IL-2, and therefore represents a totally self-supporting system.

OriginalspracheEnglisch
Seiten (von - bis)1246-1252
Seitenumfang7
FachzeitschriftJournal of Immunology
Jahrgang163
Ausgabenummer3
PublikationsstatusVeröffentlicht - 1 Aug. 1999
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren